CARBOXYMETHYLCELLULOSE SODIUM

N/A

Manufactured by Allergan, Inc.

22,264 FDA adverse event reports analyzed

Last updated: 2026-04-14

About CARBOXYMETHYLCELLULOSE SODIUM

CARBOXYMETHYLCELLULOSE SODIUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Allergan, Inc.. The most commonly reported adverse reactions for CARBOXYMETHYLCELLULOSE SODIUM include DRUG INEFFECTIVE, EYE PAIN, MACULAR DEGENERATION, EYE IRRITATION, OFF LABEL USE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CARBOXYMETHYLCELLULOSE SODIUM.

Top Adverse Reactions

DRUG INEFFECTIVE1,361 reports
EYE PAIN925 reports
MACULAR DEGENERATION878 reports
EYE IRRITATION869 reports
OFF LABEL USE588 reports
NAUSEA574 reports
VISION BLURRED533 reports
HEADACHE510 reports
CATARACT455 reports
PAIN453 reports
OCULAR HYPERAEMIA430 reports
FATIGUE424 reports
DRY EYE415 reports
MALAISE399 reports
WEIGHT DECREASED373 reports
PYREXIA319 reports
DYSPNOEA292 reports
DIARRHOEA291 reports
CONSTIPATION288 reports
ERYTHEMA264 reports
ABDOMINAL PAIN254 reports
DYSPEPSIA247 reports
LACRIMATION INCREASED246 reports
DIZZINESS244 reports
FALL241 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE239 reports
ANAEMIA235 reports
VISUAL IMPAIRMENT235 reports
INFUSION RELATED REACTION233 reports
PARAESTHESIA ORAL221 reports
CHRONIC SINUSITIS218 reports
PRODUCT DOSE OMISSION ISSUE216 reports
EYE PRURITUS214 reports
ASTHENIA213 reports
FOREIGN BODY SENSATION IN EYES206 reports
PROCEDURAL PAIN206 reports
COUGH196 reports
VOMITING196 reports
ORAL CANDIDIASIS184 reports
PNEUMONIA182 reports
RECTAL HAEMORRHAGE181 reports
ARTHRALGIA180 reports
BACK PAIN177 reports
EYE SWELLING176 reports
HAEMATOCHEZIA176 reports
PHOTOPHOBIA176 reports
COLITIS175 reports
PRURITUS173 reports
FREQUENT BOWEL MOVEMENTS172 reports
INSOMNIA170 reports
RADICULOPATHY167 reports
FEMALE GENITAL TRACT FISTULA165 reports
VAGINAL DISCHARGE165 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS165 reports
COLITIS ULCERATIVE164 reports
PROCTITIS164 reports
VAGINAL FLATULENCE163 reports
OCULAR DISCOMFORT160 reports
EYE DISCHARGE155 reports
DEATH153 reports
RASH152 reports
URINARY TRACT INFECTION140 reports
EYE DISORDER135 reports
PAIN IN EXTREMITY134 reports
GAIT DISTURBANCE118 reports
INCORRECT DOSE ADMINISTERED115 reports
NASOPHARYNGITIS109 reports
DECREASED APPETITE107 reports
COVID 19102 reports
HYPERTENSION99 reports
MUSCLE SPASMS99 reports
SOMNOLENCE99 reports
ANXIETY98 reports
HYPERSENSITIVITY98 reports
BLOOD PRESSURE INCREASED97 reports
CONDITION AGGRAVATED97 reports
CONFUSIONAL STATE97 reports
DRUG HYPERSENSITIVITY94 reports
GLAUCOMA94 reports
FEELING ABNORMAL93 reports
EYE INFECTION92 reports
HYPOTENSION90 reports
PRODUCT CONTAINER ISSUE89 reports
PRODUCT QUALITY ISSUE89 reports
EYELID PAIN88 reports
WEIGHT INCREASED88 reports
HYPOAESTHESIA83 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION83 reports
MYALGIA83 reports
VISUAL ACUITY REDUCED83 reports
PRODUCT USE ISSUE81 reports
DRUG DOSE OMISSION80 reports
PERIPHERAL SWELLING80 reports
ALOPECIA77 reports
BLINDNESS77 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION77 reports
SEPSIS77 reports
CHEST PAIN76 reports
SINUSITIS76 reports
DRY MOUTH74 reports

Report Outcomes

Out of 8,881 classified reports for CARBOXYMETHYLCELLULOSE SODIUM:

Serious 53.3%Non-Serious 46.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female6,259 (75.4%)
Male2,030 (24.4%)
Unknown16 (0.2%)

Reports by Age

Age 71209 reports
Age 65196 reports
Age 66160 reports
Age 74140 reports
Age 77138 reports
Age 78138 reports
Age 64137 reports
Age 69137 reports
Age 73133 reports
Age 72132 reports
Age 75132 reports
Age 68129 reports
Age 76128 reports
Age 79120 reports
Age 83115 reports
Age 82113 reports
Age 80112 reports
Age 70111 reports
Age 63109 reports
Age 62107 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CARBOXYMETHYLCELLULOSE SODIUM?

This profile reflects 22,264 FDA FAERS reports that mention CARBOXYMETHYLCELLULOSE SODIUM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CARBOXYMETHYLCELLULOSE SODIUM?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, EYE PAIN, MACULAR DEGENERATION, EYE IRRITATION, OFF LABEL USE, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CARBOXYMETHYLCELLULOSE SODIUM?

Labeling and FAERS entries often list Allergan, Inc. in connection with CARBOXYMETHYLCELLULOSE SODIUM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.